Join to view full profile
1300 York AveNew York, NY 10065
Phone+1 319-471-7770
Dr. Wald is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2021 - 2027
Weill Cornell MedicineClass of 2021
Publications & Presentations
PubMed
- A Phase I Clinical Trial of Chemoimmunotherapy With Alternating Intravesical Gemcitabine and Bacillus Calmette-Guérin (GemBCG) for BCG-Exposed High-Grade Non-Muscle-In...Christopher D Gaffney, Syed Muneeb Alam, Gal Wald, Daniel Sjoberg, Jordan Eichholz
The Journal of Urology. 2026-10-01 - Predictors of fluoroquinolone-resistant bacterial colonization prior to prostate biopsy: a secondary analysis of two randomized trials.Daniel Barbakoff, Gal Wald, Mary Oakley Strasser, Rebecca Yu, Joshua Winograd
Prostate Cancer and Prostatic Diseases. 2026-10-01 - Use of pelvic lymph node dissection among men undergoing radical prostatectomy in the US: Population-based analysis between 2010 and 2020.Hriday P Bhambhvani, Gal Wald, Anjile An, Neal Patel, Daniel A Barocas
Urologic Oncology. 2026-10-01
Press Mentions
AUA 2026: Final Results of a Phase II Trial of BCG and Intravesical Gemcitabine for Patients with BCG-Exposed High-Grade Non-Muscle Invasive Bladder CancerJune 24th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
